IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
-1.15%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
AUM
$320M
AUM Growth
+$320M
Cap. Flow
+$6.14M
Cap. Flow %
1.92%
Top 10 Hldgs %
52.44%
Holding
116
New
16
Increased
13
Reduced
23
Closed
13
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KPTI icon
76
Karyopharm Therapeutics
KPTI
$61.4M
$355K 0.06%
27,290
LYRA icon
77
Lyra Therapeutics
LYRA
$11.8M
$292K 0.05%
21,137
AEON icon
78
AEON Biopharma
AEON
$9.43M
$271K 0.05%
3,583
TPST icon
79
Tempest Therapeutics
TPST
$46.6M
$231K 0.04%
8,123
CMMB
80
Chemomab Therapeutics
CMMB
$15.7M
$196K 0.03%
53,348
RLMD icon
81
Relmada Therapeutics
RLMD
$48.8M
$121K 0.02%
40,369
STOK icon
82
Stoke Therapeutics
STOK
$1.08B
$92.1K 0.02%
6,816
SYBX icon
83
Synlogic
SYBX
$17.4M
$30.7K 0.01%
20,448
BCLI
84
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$30.5K 0.01%
6,016
CTMX icon
85
CytomX Therapeutics
CTMX
$350M
$10.9K ﹤0.01%
+8,924
New +$10.9K
AZN icon
86
AstraZeneca
AZN
$255B
0
ALNY icon
87
Alnylam Pharmaceuticals
ALNY
$58.6B
-51,541
Closed -$7.7M
ANVS icon
88
Annovis Bio
ANVS
$44.4M
0
APLS icon
89
Apellis Pharmaceuticals
APLS
$3.51B
-35,092
Closed -$2.06M
ARE icon
90
Alexandria Real Estate Equities
ARE
$13.9B
0
ATXS icon
91
Astria Therapeutics
ATXS
$372M
-140,687
Closed -$1.98M
BHVN icon
92
Biohaven
BHVN
$1.71B
0
BMEA icon
93
Biomea Fusion
BMEA
$114M
0
CABA icon
94
Cabaletta Bio
CABA
$144M
0
CORT icon
95
Corcept Therapeutics
CORT
$7.52B
0
EYPT icon
96
EyePoint Pharmaceuticals
EYPT
$827M
-1,047
Closed -$21.6K
FDMT icon
97
4D Molecular Therapeutics
FDMT
$287M
0
CBIO
98
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
0
GPCR icon
99
Structure Therapeutics
GPCR
$1.14B
0
HOOK
100
DELISTED
HOOKIPA Pharma
HOOK
-53,078
Closed -$378K